Sotabase

Career

· Quantitative Researcher, Jump Trading Group2024–
· Research Assistant, Berkeley Artificial Intelligence Research (BAIR)2020–
· Graduate Student, University of California, Berkeley2020–
· Software Engineer, Texas Instruments1988–1993
· Master of Sciences, Industrial Engineering and Operations Research, University of California, Berkeley1986–1988
· Bachelor of Sciences, Industrial Engineering, Manipal Institute of Technology1982–1986

Publications (175)

Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria.
Molecular and biochemical parasitology (Print) · 2006
174
cited
Immunosuppression in liver transplantation.
Current Drug Targets · 2009
141
cited
A Comprehensive Review of Immunosuppression Used for Liver Transplantation
Journal of Transplantation · 2009
127
cited
The profile of bile acids and their sulfate metabolites in human urine and serum.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2013
115
cited
Viruses use stealth technology to escape from the host immune system.
Molecular medicine today · 1997
87
cited
Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation
American Journal of Gastroenterology · 2003
65
cited
Urinary bile acids as biomarkers for liver diseases I. Stability of the baseline profile in healthy subjects.
Toxicological Sciences · 2015
53
cited
Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
Toxicological Sciences · 2015
43
cited
Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease
Liver transplantation · 2006
41
cited
Impact of pegylated interferon α‐2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open‐label series
Liver international (Print) · 2006
37
cited
Diarrhea associated with lansoprazole
Journal of Gastroenterology and Hepatology · 2003
35
cited
Controversies in liver transplantation for hepatitis C.
Gastroenterology · 2008
34
cited
Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus
Rheumatology · 2018
34
cited
Managing Post-Transplant Lymphoproliferative Disorders in Solid-Organ Transplant Recipients
Drugs · 2012
30
cited
Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation
Liver international (Print) · 2007
30
cited
Potential Serological Use of a Recombinant Protein That Is a Replica of a Mycobacterium tuberculosis Protein Found in the Urine of Infected Mice
Clinical Diagnostic Laboratory Immunology · 2004
30
cited
Expandable metal stents in achalasia—is there a role?
American Journal of Gastroenterology · 2000
27
cited
Treat-to-target in PsA: methods and necessity
RMD Open · 2020
27
cited
Impact of pegylated interferon alfa-2a and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series.
Hepato-Gastroenterology · 2006
26
cited
Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: Cohort study of 38 patients
Journal of Gastroenterology and Hepatology · 2005
25
cited
Sotabase
Sandeep Mukherjee | Researcher Profile | Sotabase | Sotabase